Delivery Order SPE2DB22D2206-SPE2DB23FHL29
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $10,281.49 firm fixed price delivery order is for the provision of REVLIMID 25 MG CAPSULE 21S pharmaceutical products. The contract has no set-aside designation and the performance location is Amerisourcebergen's corporate headquarters in Conshohocken,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order for the supply of REVLIMID 25 MG CAPSULE 100S, a pharmaceutical product, with a potential value of $107,931.18. The contract has a completion date of March 20, 2023. No set-aside designation was used. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of REVLIMID 10 MG Capsules. The award has a ceiling value of $105,612.88 and an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $187,225.54, is for the supply of Revlimid 10 mg capsules and has an ultimate completion date of October 18, 2024. This is a delivery order contract with a firm fixed-price pricing type, and there was no set-aside used. Amerisourcebergen, as a major pharmaceutical distributor in the United States, has been awarded...
- This federal contract award, valued at $28,471.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, with a completion date of January 8, 2024. This is a firm fixed price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is an established prime contractor providing a wide range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4557530338 - REVLIMID 5 MG CAPSULE 100S. The $160,303.95 firm fixed price delivery order contract has a completion date of July 5, 2022 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REVLIMID 25 MG CAPSULE 21S. The delivery order contract, valued at $18,722.57, is a firm fixed-price arrangement with an ultimate completion date of August 22, 2024. Amerisourcebergen, through its Corporate Office division, will provide these pharmaceutical products to support the healthcare needs of federal agencies and their...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, worth $20,562.98, is for the delivery of REVLIMID 25 MG CAPSULE 21S, a specialty pharmaceutical product. The contract has an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $178,310.12, is a Firm Fixed Price Delivery Order for the supply of REVLIMID 10 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of April 11, 2025 and was awarded on March 21, 2025. The contract is not designated with a set-aside requirement, indicating open...
- This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office division, valued at $356,620.24, for the supply of REVLIMID 10 MG CAPSULE 100S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 20, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FHL29Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $107,912.38 firm fixed price delivery order is for the supply of REVLIMID 10 mg capsule 100s to DLA Troop Support Medical facilities. The contract has a completion date of June 22, 2023 and does not include a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, has an extensive history of providing pharmaceutical products and medical supplies to support Department of Defense programs. The company also holds a separate $750,000 indefinite delivery contract with the Federal Bureau of Investigation Headquarters Division to supply medical supplies and prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $107.9k | 5/31/23 |